Dysregulation of the Wnt/β-catenin pathway due to Axin1 mutations is associated with various cancers, especially gastrointestinal (GI) cancers, such as hepatocellular carcinoma (HCC), gastric cancer, and colorectal cancer. This evidence concerns the gene AXIN1 and hepatocellular carcinoma.